Lifeward Announces CEO Transition

Core Points - Lifeward Ltd. announces the retirement of CEO Larry Jasinski after 13 years, with a transition period extending through Q2 2025 [1][4] - The company has initiated a search for a new CEO, considering both internal and external candidates [2] - Lifeward expects to report approximately $25.7 million in revenue for the year ended December 31, 2024, within its guidance range of$25 million to $26 million [3] - The company anticipates annual GAAP operating expenses of about$33.4 million, including $5.7 million in restructuring and impairment expenses [3] - A virtual investor event originally scheduled for February 20, 2025, will be rescheduled to later in 2025 following the appointment of the new CEO [3] Company Overview - Lifeward is a global leader in innovative medical technology aimed at transforming the lives of individuals with physical limitations or disabilities [1][5] - The company’s product portfolio includes the ReWalk Exoskeleton, AlterG Anti-Gravity System, MyoCycle FES System, and ReStore Exo-Suit, which are designed to provide functional and health benefits in rehabilitation [5] - Founded in 2001, Lifeward operates in the United States, Israel, and Germany, focusing on delivering groundbreaking solutions for physical rehabilitation [5]